Cannara Biotech (TSX:LOVE) EPS (Basic): C$0.11 (TTM As of Feb. 2026)


TSX:LOVE Cannara Biotech Inc TSX:LOVE
92 GF Score
Price C$1.68
GF Value C$1.68
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Cannara Biotech EPS (Basic)?

Cannara Biotech TSX:LOVE +5.00% 92 EPS (Basic) is C$0.11 as of Feb. 2026. GuruFocus rates TSX:LOVE with a GF Score™ of 92/100 and a GF Value™ of C$1.68 (Fairly Valued). The stock has 4 warning signs investors should review.

Cannara Biotech's basic earnings per share (Basic EPS) for the three months ended in Feb. 2026 was C$0.02. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Feb. 2026 was C$0.11.

Cannara Biotech's EPS (Diluted) for the three months ended in Feb. 2026 was C$0.02. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Feb. 2026 was C$0.10.

Cannara Biotech's EPS without NRI for the three months ended in Feb. 2026 was C$0.02. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Feb. 2026 was 0.10.

During the past 12 months, Cannara Biotech's average EPS without NRIGrowth Rate was -24.00% per year. During the past 3 years, the average EPS without NRI Growth Rate was 76.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 8 years, Cannara Biotech's highest 3-Year average EPS without NRI Growth Rate was 76.30% per year. The lowest was -48.40% per year. And the median was 13.95% per year.

Cannara Biotech  (TSX:LOVE) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Cannara Biotech EPS (Basic) Related Terms

Cannara Biotech EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Cannara Biotech's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannara Biotech EPS (Basic) Chart

Cannara Biotech Annual Data
Trend Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
EPS (Basic)
Get a 7-Day Free Trial -0.10 0.03 0.08 0.07 0.14

Cannara Biotech Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.05 0.03 0.01 0.02
TSX:LOVE
92GF Score
Cannara Biotech Inc TSX:LOVE
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cannara Biotech EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Cannara Biotech's Basic EPS for the fiscal year that ended in Aug. 2025 is calculated as

Basic EPS (A: Aug. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(13.076-0)/90.865
=0.14

Cannara Biotech's Basic EPS for the quarter that ended in Feb. 2026 is calculated as

Basic EPS (Q: Feb. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(1.663-0)/96.358
=0.02

EPS (Basic) for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of C$0.11 mean?
Cannara Biotech (TSX:LOVE) has a EPS (Basic) of C$0.11 as of Feb. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Cannara Biotech and its competitors.
Is Cannara Biotech's EPS (Basic) too high?
Cannara Biotech's current EPS (Basic) is C$0.11. Overall, Cannara Biotech has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cannara Biotech's EPS (Basic) compare to ZTS?
Cannara Biotech's EPS (Basic) of C$0.11 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Cannara Biotech and its competitors. Cannara Biotech's current EPS (Basic) is C$0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannara Biotech stock overvalued right now?
Based on GuruFocus' analysis, Cannara Biotech (TSX:LOVE) is currently considered Fairly Valued. The stock's GF Value™ is C$1.68, compared to a current price of C$1.68 — trading right at its estimated fair value. The current EPS (Basic) is C$0.11. Cannara Biotech's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Cannara Biotech (TSX:LOVE), the current EPS (Basic) is C$0.11 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cannara Biotech (TSX:LOVE) Overvalued in 2026?

Based on GuruFocus' analysis, Cannara Biotech stock appears to be undervalued. The current stock price of C$1.68 is trading 0% below its estimated GF Value™ of C$1.68. GuruFocus considers Cannara Biotech to be Fairly Valued.

Key valuation signals for TSX:LOVE:

  • EPS (Basic): C$0.11
  • GF Value™: C$1.68 vs. price of C$1.68 (0% below fair value)
  • GF Score™: 92/100 with 4 warning signs

No single metric tells the full story. See the TSX:LOVE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cannara Biotech Business Description

Other Exchanges LOVFF:USA8CB0:Germany
Address 1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3
Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .
92GF Score

Get the complete analysis for TSX:LOVE

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$1.68
Price
C$1.68
GF Value